Kristin Yarema, Ph.D.

Chief Financial Officer, ImageneBio, Inc.

Former. First published here October 28, 2026; built from records as of October 28, 2026.

ImageneBio, Inc. named Yanina Grant-Huerta to succeed Kristin Yarema, Ph.D., effective July 20, 2026.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
ImageneBio, Inc. (IMA) Biological Products, (No Diagnostic Substances)	Not stated	Former	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

July 20, 2026effective
ImageneBio, Inc. named Yanina Grant-Huerta to succeed Kristin Yarema, Ph.D., effective July 20, 2026. Profile of Yanina Grant-Huerta.
On July 20, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), based in part on the recommendation of Kristin Yarema, Ph.D., the Company’s Chief Executive Officer, appointed Yanina Grant-Huerta as the Company’s Chief Financial Officer, principal financial officer […]
[1] Filing by ImageneBio, Inc., filed with the SEC on July 23, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, ImageneBio, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed July 23, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Kristin Yarema, Ph.D. wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.